Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$80.11 - $90.62 $216,297 - $244,674
-2,700 Closed
0 $0
Q4 2021

Feb 04, 2022

BUY
$79.7 - $88.13 $6,216 - $6,874
78 Added 2.97%
2,700 $236,000
Q3 2021

Nov 12, 2021

SELL
$81.78 - $95.14 $12,267 - $14,271
-150 Reduced 5.41%
2,622 $214,000
Q2 2021

Aug 10, 2021

BUY
$85.24 - $94.15 $13,467 - $14,875
158 Added 6.04%
2,772 $253,000
Q1 2021

May 10, 2021

SELL
$83.5 - $98.47 $334 - $393
-4 Reduced 0.15%
2,614 $223,000
Q4 2020

Feb 08, 2021

SELL
$78.07 - $94.43 $1,483 - $1,794
-19 Reduced 0.72%
2,618 $247,000
Q3 2020

Nov 12, 2020

SELL
$82.14 - $91.0 $8,953 - $9,919
-109 Reduced 3.97%
2,637 $229,000
Q2 2020

Aug 07, 2020

SELL
$80.93 - $91.1 $7,607 - $8,563
-94 Reduced 3.31%
2,746 $240,000
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $27,843 - $39,009
-394 Reduced 12.18%
2,840 $234,000
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $674 - $762
-8 Reduced 0.25%
3,234 $306,000
Q3 2019

Nov 07, 2019

SELL
$85.54 - $94.26 $31,820 - $35,064
-372 Reduced 10.29%
3,242 $282,000
Q2 2019

Aug 05, 2019

SELL
$75.4 - $92.8 $204,032 - $251,116
-2,706 Reduced 42.82%
3,614 $0
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $30,429 - $34,804
404 Added 6.83%
6,320 $608,000
Q4 2018

Feb 13, 2019

BUY
$73.66 - $82.02 $1,694 - $1,886
23 Added 0.39%
5,916 $508,000
Q3 2018

Nov 13, 2018

SELL
$66.94 - $77.43 $35,478 - $41,037
-530 Reduced 8.25%
5,893 $508,000
Q2 2018

Aug 13, 2018

BUY
$64.91 - $73.36 $196,222 - $221,767
3,023 Added 88.91%
6,423 $485,000
Q1 2018

May 03, 2018

BUY
$70.39 - $84.15 $915 - $1,093
13 Added 0.38%
3,400 $275,000
Q4 2017

Feb 13, 2018

SELL
$72.33 - $77.64 $6,799 - $7,298
-94 Reduced 2.7%
3,387 $284,000
Q3 2017

Nov 07, 2017

BUY
$74.14 - $77.27 $258,081 - $268,976
3,481
3,481 $299,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Wintrust Investments LLC Portfolio

Follow Wintrust Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wintrust Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wintrust Investments LLC with notifications on news.